Minnesota Food Companies Factoring How Weight-loss Drugs Affect Snack Sales

Trending 1 week ago

Years ago, Robyn Munsch would rotation hungrily astir nan market shop and time off pinch calorie-dense foods for illustration a stiff pizza, cookies and frosting. That was earlier she started taking Wegovy and mislaid 85 pounds.

“I nary longer bargain chips, sweets aliases different junk foods,” nan Rochester female said. “I conscionable don’t crave it. It’s life-changing.”

It’s besides game-changing for nan nutrient industry, since Munsch is 1 of millions taking GLP-1 drugs, a people of medications primitively intended for glucosuria curen that person grown successful fame precocious arsenic a weight-loss remedy. Those connected Ozempic, Trulicity and different brand-name meds are eating acold little packaged nutrient arsenic a result, and millions much will subordinate nan ranks successful nan years to come.

Businesses built connected irresistible products are facing unprecedented resistance. Appetite-suppressing medications that an estimated 10% of American adults usage are disrupting market shopping.

Savory snacks, sweets, refrigerated mixed and dozens of different market categories person seen a meaningful diminution among GLP-1 users, according to a Cornell University and Numerator survey.

“Our findings item nan imaginable for GLP-1 medications to importantly alteration nutrient demand, a inclination pinch progressively important implications for nan nutrient manufacture arsenic GLP-1 take continues to grow,” nan study concluded.

Yet nutrient companies from Hershey to Hormel are waving disconnected nan effect of GLP-1 drugs, moreover arsenic they’ve been dropping weight themselves. The measurement of nutrient those and different companies waste has declined successful caller years.

Meanwhile, a PwC study recovered GLP-1 users’ nutrient spending drops by 11%, and Morgan Stanley analysts person predicted nan narcotics will origin an wide diminution successful nutrient sold done nan adjacent decade moreover arsenic nan U.S. organization continues to grow.

“This year, we’re targeting GLP-1 consumers and telling them really Progresso macromolecule and fibre benefits tin fresh seamlessly into their caller routine,” CEO Jeff Harmening said astatine an manufacture convention successful February.

Even pinch Progresso’s Pitmaster soups and protein-enhanced Nature Valley bars, nan Golden Valley-based institution makes overmuch of its $19 cardinal successful yearly income from nan benignant of carbs GLP-1 users nary longer crave.

“A container of cereal will past maine 2 weeks,” Munsch said. “That would person ne'er happened earlier taking GLP-1.”

That’s a sentiment a increasing number of consumers share. About 10% of American adults are presently connected GLP-1 medication, Harmening said, but he maintains that General Mills has not taken a income deed because of it, echoing what different nutrient execs are saying.

“I honestly deliberation it’s a nett use for General Mills,” Harmening said successful an question and reply past month. “Consumers, moreover those connected GLP-1s, still want worldly that tastes good. They want them successful nan correct proportions.”

Consumers' buying habits are changing arsenic much spell connected GLP-1 drugs. (SCOTT MCINTYRE/The New York Times)

Tastes change; will it last?

More